BioNxt Solutions
  • About Us
    • About Us
    • Our Team
  • Our Science
  • Our Pipeline
    • Our Pipeline
    • BNT23001 Next-Gen Solution for Multiple sclerosis (MS)
    • BNT23002: Breakthrough Therapy for Myasthenia Gravis (MG)
    • BNT24002: Advanced Treatment for Lupus Nephritis (LN)
    • BNT24003: Innovating Treatment for Rheumatoid Arthritis (RA)
    • BNT24004: Breakthrough Solution for Longevity and Anti-Aging
    • BNT24004: Innovating Semaglutide Delivery with Thin-Film Technology
  • News
  • Investors
    • Investors
    • Press Releases
    • Сorporate Presentation
  • Contact
  • Home

Our News & Updates

Page: 8

Show All Press Releases Diagnostics Psychedelics Drug Delivery

Diagnostics, Press Releases

Infectious Disease Oral Screening Test Advancement

Jun 15, 2020

Vancouver, Canada (June 15, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...

Continue Reading

Diagnostics, Press Releases

Diagnostic Partner 3a Receives BMBF Grant for Infectious Disease Screening Tests

Jun 10, 2020

Vancouver, Canada (June 10, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its diagnostic...

Continue Reading

Drug Delivery, Press Releases

Parkinson’s Generic Transdermal Drug Delivery System

Jun 8, 2020

Vancouver, Canada (June 8, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...

Continue Reading

Press Releases, Psychedelics

Exclusive Agreement with Oettinger Brewery for Cannabis-Infused Beverages signed

May 12, 2020

Vancouver, Canada (May 12, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...

Continue Reading

Diagnostics, Press Releases

Infectious Disease Oral Dissolvable Biosensor Development

Apr 22, 2020

Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...

Continue Reading

Diagnostics, Press Releases

COVID-19 Screening Test, Oral Thin Film Biosensor Products and Identification Platform

Apr 20, 2020

Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...

Continue Reading

Press Releases

Exclusive Advisory Agreement for COVID-19 and Host Cell Interactions Signed

Mar 25, 2020

Vancouver, Canada (March 25, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that an exclusive infectious disease...

Continue Reading

Diagnostics, Press Releases

COVID-19 Test and Development Programs Update

Mar 20, 2020

Vancouver, Canada (March 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce updates to its infectious disease...

Continue Reading

Drug Delivery, Press Releases

Update on XPhyto’s Epilepsy Treatment Program

Mar 18, 2020

Vancouver, Canada (March 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce significant progress with respect to development...

Continue Reading

Diagnostics, Press Releases

XPhyto Initiates Infectious Disease Programs

Mar 3, 2020

Vancouver, Canada (March 03, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...

Continue Reading

Press Releases

Exclusive Strategic Partnership Commenced with Elite Bavarian Brewing & Beverage Institute Weihenstephan (TUM)

Feb 18, 2020

Vancouver, Canada (February 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...

Continue Reading

Press Releases

Three Year Strategic Supply, Import and Distribution Agreement with PharmaCielo Ltd. signed

Jan 27, 2020

Vancouver, Canada (January 27, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company has signed a...

Continue Reading
Page 8 of 10‹‹‹5678910›
Scientist looking in magnifying glass XPhyto
Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.

  • About BioNxt
  • Our Team
  • Our Companies
  • Careers
  • Investor Relations
  • Corporate Presentation (PDF)
  • Press Releases
  • Request Info
  • Legal Information
  • Cautionary Note
  • Privacy Policy
  • Contact
Xphyto test tubes in laboratory footer
Copyright © 2025 BioNxt Solutions
This website uses cookies and third party services. By clicking “Accept”, you consent to the use of all cookies
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT